Mary Weiser-Evans
Concepts (421)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Smooth Muscle | 21 | 2023 | 239 | 4.330 |
Why?
| PTEN Phosphohydrolase | 13 | 2020 | 142 | 4.080 |
Why?
| Muscle, Smooth, Vascular | 25 | 2023 | 420 | 3.920 |
Why?
| Vascular Remodeling | 8 | 2022 | 151 | 2.880 |
Why?
| Atherosclerosis | 4 | 2023 | 341 | 2.410 |
Why?
| Plaque, Atherosclerotic | 2 | 2023 | 43 | 1.730 |
Why?
| Adventitia | 2 | 2022 | 37 | 1.360 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2020 | 61 | 1.250 |
Why?
| Stem Cells | 6 | 2023 | 546 | 1.160 |
Why?
| Fibrosis | 12 | 2023 | 457 | 1.160 |
Why?
| Lung Neoplasms | 19 | 2023 | 2207 | 1.090 |
Why?
| Vascular System Injuries | 3 | 2023 | 64 | 1.020 |
Why?
| Mice | 42 | 2023 | 15052 | 1.010 |
Why?
| Cell Proliferation | 18 | 2021 | 2194 | 0.970 |
Why?
| Myofibroblasts | 2 | 2023 | 116 | 0.960 |
Why?
| Neointima | 4 | 2022 | 13 | 0.880 |
Why?
| Animals | 62 | 2023 | 32102 | 0.850 |
Why?
| Hypercholesterolemia | 1 | 2023 | 92 | 0.840 |
Why?
| Tunica Intima | 5 | 2010 | 78 | 0.830 |
Why?
| Spinocerebellar Ataxias | 1 | 2022 | 4 | 0.820 |
Why?
| Galectin 3 | 1 | 2022 | 18 | 0.820 |
Why?
| Cell Differentiation | 10 | 2023 | 1700 | 0.800 |
Why?
| Heart-Assist Devices | 4 | 2022 | 486 | 0.760 |
Why?
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 14 | 0.720 |
Why?
| Serum Response Factor | 3 | 2016 | 27 | 0.690 |
Why?
| Carotid Artery Injuries | 5 | 2010 | 43 | 0.680 |
Why?
| Mice, Inbred C57BL | 21 | 2023 | 4773 | 0.680 |
Why?
| Chemokine CXCL12 | 2 | 2011 | 74 | 0.670 |
Why?
| Coronary Restenosis | 1 | 2019 | 18 | 0.670 |
Why?
| Cyclin D1 | 1 | 2019 | 61 | 0.670 |
Why?
| Coronary Vessels | 2 | 2018 | 229 | 0.660 |
Why?
| High-Throughput Screening Assays | 1 | 2020 | 124 | 0.640 |
Why?
| Tumor Microenvironment | 8 | 2021 | 431 | 0.610 |
Why?
| Arteries | 4 | 2022 | 250 | 0.590 |
Why?
| Rats | 20 | 2019 | 5034 | 0.570 |
Why?
| Vascular Diseases | 1 | 2019 | 230 | 0.560 |
Why?
| Mice, Knockout | 15 | 2021 | 2604 | 0.550 |
Why?
| Heparan Sulfate Proteoglycans | 4 | 2003 | 22 | 0.540 |
Why?
| Mice, Transgenic | 9 | 2020 | 1970 | 0.530 |
Why?
| Cells, Cultured | 17 | 2021 | 3914 | 0.520 |
Why?
| PPAR gamma | 7 | 2019 | 185 | 0.510 |
Why?
| Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 963 | 0.500 |
Why?
| Gene Expression Regulation | 5 | 2019 | 2353 | 0.490 |
Why?
| Acute Kidney Injury | 5 | 2023 | 646 | 0.480 |
Why?
| Hypertension | 1 | 2022 | 1064 | 0.470 |
Why?
| Hypertension, Pulmonary | 5 | 2023 | 1749 | 0.470 |
Why?
| Disease Models, Animal | 16 | 2023 | 3580 | 0.460 |
Why?
| Cell Division | 8 | 2004 | 759 | 0.460 |
Why?
| Signal Transduction | 18 | 2019 | 4541 | 0.460 |
Why?
| MicroRNAs | 2 | 2017 | 607 | 0.440 |
Why?
| Hyperplasia | 5 | 2020 | 166 | 0.440 |
Why?
| Protein Kinases | 4 | 2014 | 306 | 0.410 |
Why?
| Bone Marrow Cells | 2 | 2011 | 268 | 0.390 |
Why?
| Transforming Growth Factor beta1 | 3 | 2023 | 156 | 0.380 |
Why?
| Kidney | 6 | 2021 | 1207 | 0.380 |
Why?
| Cell Movement | 5 | 2012 | 867 | 0.370 |
Why?
| Ureteral Obstruction | 3 | 2021 | 54 | 0.370 |
Why?
| Macrophages | 4 | 2021 | 1284 | 0.360 |
Why?
| Muscle, Smooth | 2 | 2023 | 150 | 0.350 |
Why?
| Autocrine Communication | 2 | 2014 | 43 | 0.330 |
Why?
| Cell Dedifferentiation | 3 | 2016 | 28 | 0.330 |
Why?
| Angiotensin II | 3 | 2021 | 91 | 0.330 |
Why?
| Phospholipases A2, Cytosolic | 1 | 2009 | 6 | 0.330 |
Why?
| Cisplatin | 3 | 2020 | 263 | 0.320 |
Why?
| Platelet-Derived Growth Factor | 4 | 2020 | 82 | 0.310 |
Why?
| Group IV Phospholipases A2 | 3 | 2017 | 45 | 0.310 |
Why?
| Male | 25 | 2023 | 55968 | 0.310 |
Why?
| Hypoxia | 2 | 2013 | 937 | 0.300 |
Why?
| Carcinoma, Lewis Lung | 2 | 2019 | 13 | 0.300 |
Why?
| Heart Failure | 4 | 2023 | 1964 | 0.290 |
Why?
| Proteins | 2 | 2006 | 920 | 0.290 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 36 | 0.290 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 4 | 2019 | 27 | 0.290 |
Why?
| Proto-Oncogene Proteins c-akt | 7 | 2014 | 400 | 0.290 |
Why?
| Nuclear Proteins | 2 | 2023 | 594 | 0.290 |
Why?
| Rats, Sprague-Dawley | 9 | 2016 | 2262 | 0.290 |
Why?
| Actins | 3 | 2018 | 383 | 0.280 |
Why?
| TOR Serine-Threonine Kinases | 5 | 2014 | 362 | 0.280 |
Why?
| Proto-Oncogene Proteins | 3 | 2004 | 609 | 0.270 |
Why?
| Adenocarcinoma | 5 | 2017 | 799 | 0.270 |
Why?
| Acetyltransferases | 1 | 2006 | 20 | 0.260 |
Why?
| Endothelial Cells | 2 | 2022 | 695 | 0.260 |
Why?
| Inflammation | 4 | 2023 | 2500 | 0.260 |
Why?
| Polycystic Kidney, Autosomal Dominant | 2 | 2019 | 209 | 0.260 |
Why?
| Protein-Tyrosine Kinases | 3 | 2003 | 396 | 0.260 |
Why?
| RNA Interference | 5 | 2014 | 438 | 0.250 |
Why?
| Embryonic Development | 1 | 2006 | 115 | 0.250 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2010 | 332 | 0.240 |
Why?
| Humans | 32 | 2023 | 115613 | 0.240 |
Why?
| Myeloid Cells | 2 | 2019 | 127 | 0.240 |
Why?
| Gene Expression | 3 | 2014 | 1436 | 0.240 |
Why?
| Ribosomal Protein S6 | 1 | 2004 | 15 | 0.230 |
Why?
| Inflammation Mediators | 2 | 2021 | 479 | 0.230 |
Why?
| Corn Oil | 1 | 2023 | 3 | 0.230 |
Why?
| Receptors, LDL | 1 | 2023 | 39 | 0.220 |
Why?
| Azotemia | 1 | 2023 | 6 | 0.220 |
Why?
| Proprotein Convertase 9 | 1 | 2023 | 61 | 0.220 |
Why?
| Disease Progression | 7 | 2019 | 2418 | 0.220 |
Why?
| Phosphorylation | 6 | 2019 | 1571 | 0.220 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2004 | 147 | 0.210 |
Why?
| Lipoxygenase Inhibitors | 2 | 2021 | 36 | 0.210 |
Why?
| Phenotype | 9 | 2021 | 2831 | 0.210 |
Why?
| Extracellular Matrix | 4 | 2021 | 439 | 0.210 |
Why?
| Rejuvenation | 1 | 2022 | 14 | 0.210 |
Why?
| Zebrafish | 1 | 2006 | 412 | 0.200 |
Why?
| Programmed Cell Death 1 Receptor | 3 | 2020 | 193 | 0.200 |
Why?
| Polycystic Kidney Diseases | 2 | 2019 | 55 | 0.200 |
Why?
| Cell Line, Tumor | 9 | 2019 | 2751 | 0.200 |
Why?
| Cytokines | 4 | 2021 | 1853 | 0.200 |
Why?
| DNA Helicases | 1 | 2023 | 133 | 0.200 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2021 | 13 | 0.200 |
Why?
| Arachidonate 15-Lipoxygenase | 1 | 2021 | 16 | 0.200 |
Why?
| Aortic Valve Insufficiency | 1 | 2022 | 44 | 0.200 |
Why?
| Nephritis | 1 | 2021 | 20 | 0.200 |
Why?
| Cholesterol | 1 | 2023 | 369 | 0.200 |
Why?
| Assisted Circulation | 1 | 2021 | 25 | 0.190 |
Why?
| Metformin | 2 | 2023 | 278 | 0.190 |
Why?
| Transcription Factors | 4 | 2023 | 1528 | 0.190 |
Why?
| Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.190 |
Why?
| Adaptive Immunity | 2 | 2023 | 157 | 0.190 |
Why?
| Promoter Regions, Genetic | 5 | 2020 | 1122 | 0.190 |
Why?
| Female | 16 | 2023 | 59932 | 0.190 |
Why?
| Protein Kinase Inhibitors | 3 | 2023 | 790 | 0.190 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2017 | 965 | 0.180 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2021 | 142 | 0.180 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 222 | 0.180 |
Why?
| Homeostasis | 2 | 2022 | 577 | 0.180 |
Why?
| Antineoplastic Agents, Immunological | 2 | 2019 | 154 | 0.180 |
Why?
| Aortic Diseases | 1 | 2021 | 95 | 0.180 |
Why?
| Blotting, Western | 3 | 2019 | 1153 | 0.180 |
Why?
| Wound Healing | 1 | 2022 | 257 | 0.180 |
Why?
| Jugular Veins | 1 | 2020 | 38 | 0.180 |
Why?
| Myocytes, Cardiac | 2 | 2014 | 457 | 0.170 |
Why?
| Intestines | 1 | 2023 | 324 | 0.170 |
Why?
| Crohn Disease | 1 | 2023 | 197 | 0.170 |
Why?
| Arachidonate 5-Lipoxygenase | 2 | 2019 | 45 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 114 | 0.170 |
Why?
| Chromatin | 1 | 2023 | 429 | 0.170 |
Why?
| GATA4 Transcription Factor | 1 | 2019 | 17 | 0.170 |
Why?
| Kidney Tubules | 2 | 2019 | 107 | 0.170 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 148 | 0.160 |
Why?
| Neovascularization, Physiologic | 1 | 2000 | 174 | 0.160 |
Why?
| Azacitidine | 1 | 2020 | 130 | 0.160 |
Why?
| Pulmonary Artery | 3 | 2021 | 1031 | 0.160 |
Why?
| Epigenesis, Genetic | 1 | 2023 | 526 | 0.160 |
Why?
| Catheterization | 4 | 2004 | 159 | 0.160 |
Why?
| Metabolome | 1 | 2021 | 287 | 0.160 |
Why?
| AMP-Activated Protein Kinases | 2 | 2023 | 175 | 0.160 |
Why?
| Flow Cytometry | 2 | 2019 | 1083 | 0.160 |
Why?
| Sirolimus | 2 | 2014 | 192 | 0.160 |
Why?
| Bone Marrow | 2 | 2017 | 249 | 0.160 |
Why?
| Histocompatibility Antigens Class II | 1 | 2020 | 353 | 0.160 |
Why?
| Mice, Knockout, ApoE | 1 | 2018 | 8 | 0.150 |
Why?
| Skin | 1 | 2022 | 662 | 0.150 |
Why?
| Heart Ventricles | 2 | 2021 | 712 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2019 | 167 | 0.150 |
Why?
| Interleukin-33 | 1 | 2017 | 39 | 0.150 |
Why?
| Epithelial Cells | 3 | 2019 | 961 | 0.150 |
Why?
| Trans-Activators | 1 | 2020 | 370 | 0.150 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2021 | 693 | 0.140 |
Why?
| Receptors, Complement | 1 | 2017 | 111 | 0.140 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 374 | 0.140 |
Why?
| Immunotherapy | 2 | 2018 | 479 | 0.140 |
Why?
| Energy Metabolism | 1 | 2021 | 715 | 0.140 |
Why?
| Ventricular Remodeling | 2 | 2023 | 225 | 0.130 |
Why?
| Gene Deletion | 2 | 2014 | 355 | 0.130 |
Why?
| B7-H1 Antigen | 1 | 2017 | 139 | 0.130 |
Why?
| Cell Cycle Proteins | 1 | 2019 | 553 | 0.130 |
Why?
| Interferon-gamma | 1 | 2019 | 726 | 0.130 |
Why?
| Dinoprostone | 3 | 2016 | 186 | 0.130 |
Why?
| Autophagy | 2 | 2014 | 236 | 0.130 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 388 | 0.130 |
Why?
| Focal Adhesion Kinase 1 | 3 | 2003 | 27 | 0.120 |
Why?
| NF-kappa B | 2 | 2010 | 639 | 0.120 |
Why?
| Aorta | 3 | 2004 | 353 | 0.120 |
Why?
| Complement Activation | 1 | 2017 | 343 | 0.120 |
Why?
| Interleukin-6 | 3 | 2023 | 677 | 0.120 |
Why?
| Retinoid X Receptors | 1 | 2014 | 39 | 0.120 |
Why?
| Pleural Neoplasms | 1 | 2014 | 18 | 0.120 |
Why?
| Culture Media, Serum-Free | 2 | 2004 | 42 | 0.120 |
Why?
| Mesothelioma | 1 | 2014 | 31 | 0.120 |
Why?
| Gene Amplification | 1 | 2014 | 96 | 0.120 |
Why?
| Kidney Diseases | 1 | 2017 | 354 | 0.120 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 49 | 0.120 |
Why?
| Leukotrienes | 1 | 2013 | 35 | 0.110 |
Why?
| RNA | 1 | 2019 | 819 | 0.110 |
Why?
| Paracrine Communication | 1 | 2014 | 56 | 0.110 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 488 | 0.110 |
Why?
| Oligonucleotides, Antisense | 2 | 2004 | 100 | 0.110 |
Why?
| Eicosanoids | 1 | 2013 | 55 | 0.110 |
Why?
| Monocytes | 1 | 2016 | 507 | 0.110 |
Why?
| MAP Kinase Signaling System | 3 | 2021 | 275 | 0.110 |
Why?
| Myocardial Contraction | 1 | 2014 | 316 | 0.110 |
Why?
| Macrophage Activation | 1 | 2014 | 165 | 0.110 |
Why?
| Tumor Burden | 3 | 2020 | 261 | 0.110 |
Why?
| Iloprost | 2 | 2010 | 46 | 0.110 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 120 | 0.110 |
Why?
| Macrophages, Alveolar | 1 | 2016 | 357 | 0.110 |
Why?
| Up-Regulation | 2 | 2008 | 820 | 0.100 |
Why?
| Lipocalin-2 | 2 | 2023 | 62 | 0.100 |
Why?
| Immunohistochemistry | 4 | 2021 | 1642 | 0.100 |
Why?
| T-Lymphocytes | 2 | 2017 | 1756 | 0.100 |
Why?
| Endothelium, Vascular | 1 | 2018 | 845 | 0.100 |
Why?
| Heparitin Sulfate | 2 | 2003 | 42 | 0.100 |
Why?
| Protein Processing, Post-Translational | 2 | 2004 | 401 | 0.100 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 446 | 0.100 |
Why?
| Splenectomy | 1 | 2011 | 54 | 0.090 |
Why?
| Cyclooxygenase 2 | 2 | 2010 | 164 | 0.090 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2012 | 199 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2012 | 196 | 0.090 |
Why?
| Frizzled Receptors | 1 | 2010 | 23 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 377 | 0.090 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 263 | 0.080 |
Why?
| RNA, Small Interfering | 2 | 2010 | 544 | 0.080 |
Why?
| TRPP Cation Channels | 2 | 2019 | 63 | 0.080 |
Why?
| Receptors, Epoprostenol | 1 | 2008 | 6 | 0.080 |
Why?
| Reperfusion Injury | 1 | 2011 | 254 | 0.080 |
Why?
| Lung Injury | 1 | 2011 | 199 | 0.080 |
Why?
| Antineoplastic Agents | 2 | 2017 | 1893 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2013 | 2578 | 0.080 |
Why?
| Adenosine Triphosphate | 2 | 2014 | 431 | 0.080 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2010 | 192 | 0.080 |
Why?
| Glycoproteins | 1 | 2010 | 309 | 0.080 |
Why?
| Hematopoietic Stem Cells | 1 | 2011 | 346 | 0.080 |
Why?
| Biomarkers | 4 | 2023 | 3468 | 0.080 |
Why?
| Receptors, CXCR4 | 1 | 2008 | 78 | 0.070 |
Why?
| Epoprostenol | 1 | 2008 | 133 | 0.070 |
Why?
| Cell Transformation, Neoplastic | 1 | 2010 | 314 | 0.070 |
Why?
| Gene Silencing | 2 | 2019 | 175 | 0.070 |
Why?
| Culture Media, Conditioned | 2 | 2014 | 105 | 0.070 |
Why?
| Neoplasm Metastasis | 1 | 2009 | 526 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2010 | 432 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 249 | 0.070 |
Why?
| RNA, Messenger | 5 | 2010 | 2574 | 0.070 |
Why?
| Pregnancy | 2 | 2016 | 5550 | 0.070 |
Why?
| Mutation | 3 | 2023 | 3364 | 0.060 |
Why?
| Mitogens | 1 | 2005 | 58 | 0.060 |
Why?
| Neoplasm Transplantation | 2 | 2016 | 235 | 0.060 |
Why?
| Apoptosis | 3 | 2020 | 2377 | 0.060 |
Why?
| Acetylation | 1 | 2006 | 212 | 0.060 |
Why?
| Animals, Genetically Modified | 1 | 2006 | 215 | 0.060 |
Why?
| Protein Subunits | 1 | 2006 | 204 | 0.060 |
Why?
| Gene Knockout Techniques | 2 | 2015 | 99 | 0.060 |
Why?
| Enzyme Inhibitors | 2 | 2007 | 757 | 0.060 |
Why?
| Gene Expression Profiling | 3 | 2016 | 1536 | 0.060 |
Why?
| Middle Aged | 3 | 2021 | 27014 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 157 | 0.060 |
Why?
| Cell Size | 2 | 2005 | 81 | 0.060 |
Why?
| Chromones | 1 | 2004 | 35 | 0.060 |
Why?
| Basement Membrane | 1 | 2003 | 29 | 0.060 |
Why?
| Androstadienes | 1 | 2004 | 97 | 0.060 |
Why?
| Embryo, Mammalian | 2 | 2003 | 214 | 0.060 |
Why?
| Acute-Phase Reaction | 1 | 2023 | 39 | 0.060 |
Why?
| Furosemide | 1 | 2023 | 32 | 0.060 |
Why?
| Tenascin | 1 | 2003 | 13 | 0.060 |
Why?
| Peroxidases | 1 | 2003 | 25 | 0.060 |
Why?
| Peroxidase | 2 | 2015 | 157 | 0.050 |
Why?
| Morpholines | 1 | 2004 | 103 | 0.050 |
Why?
| Glycosaminoglycans | 1 | 2003 | 80 | 0.050 |
Why?
| Fibronectins | 1 | 2003 | 108 | 0.050 |
Why?
| Aged | 2 | 2018 | 19255 | 0.050 |
Why?
| Transfection | 3 | 2014 | 866 | 0.050 |
Why?
| Murinae | 1 | 2022 | 2 | 0.050 |
Why?
| Ileum | 1 | 2023 | 93 | 0.050 |
Why?
| Aniline Compounds | 1 | 2023 | 71 | 0.050 |
Why?
| Case-Control Studies | 2 | 2021 | 3023 | 0.050 |
Why?
| Coculture Techniques | 2 | 2014 | 202 | 0.050 |
Why?
| Metalloproteases | 1 | 2022 | 37 | 0.050 |
Why?
| Cadherins | 2 | 2016 | 175 | 0.050 |
Why?
| DNA Replication | 1 | 2003 | 203 | 0.050 |
Why?
| Neoplasms | 1 | 2015 | 2118 | 0.050 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| ADAMTS4 Protein | 1 | 2021 | 16 | 0.050 |
Why?
| Cell Line | 2 | 2018 | 2651 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2003 | 246 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2023 | 251 | 0.050 |
Why?
| Cellular Microenvironment | 1 | 2021 | 78 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2003 | 616 | 0.050 |
Why?
| Vasoconstrictor Agents | 1 | 2021 | 113 | 0.050 |
Why?
| Liver | 2 | 2023 | 1690 | 0.050 |
Why?
| Major Histocompatibility Complex | 1 | 2021 | 219 | 0.040 |
Why?
| Leukocytes | 1 | 2021 | 281 | 0.040 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 51 | 0.040 |
Why?
| Butadienes | 1 | 2020 | 31 | 0.040 |
Why?
| Contractile Proteins | 1 | 2000 | 16 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2023 | 605 | 0.040 |
Why?
| Cell Fusion | 1 | 2000 | 50 | 0.040 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 49 | 0.040 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2019 | 18 | 0.040 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 336 | 0.040 |
Why?
| Thiazolidinediones | 2 | 2011 | 143 | 0.040 |
Why?
| Adult | 2 | 2018 | 30726 | 0.040 |
Why?
| Growth Substances | 1 | 2000 | 136 | 0.040 |
Why?
| Genes, Tumor Suppressor | 1 | 2000 | 78 | 0.040 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.040 |
Why?
| Enzyme Activation | 2 | 2014 | 793 | 0.040 |
Why?
| ErbB Receptors | 1 | 2023 | 557 | 0.040 |
Why?
| Pyrimidinones | 1 | 2020 | 88 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2000 | 523 | 0.040 |
Why?
| Chemokine CXCL9 | 1 | 2019 | 22 | 0.040 |
Why?
| Nitriles | 1 | 2020 | 152 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 391 | 0.040 |
Why?
| Mesoderm | 1 | 2020 | 138 | 0.040 |
Why?
| Tropoelastin | 1 | 1999 | 11 | 0.040 |
Why?
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2019 | 52 | 0.040 |
Why?
| Pyridones | 1 | 2020 | 125 | 0.040 |
Why?
| Luciferases | 2 | 2010 | 140 | 0.040 |
Why?
| Aortic Valve | 1 | 2022 | 342 | 0.040 |
Why?
| Drug Resistance, Neoplasm | 1 | 2023 | 638 | 0.040 |
Why?
| Fibroblasts | 1 | 2003 | 839 | 0.040 |
Why?
| Proteoglycans | 1 | 1999 | 107 | 0.040 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 228 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2003 | 794 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 930 | 0.040 |
Why?
| Antibodies, Blocking | 1 | 2017 | 32 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2010 | 850 | 0.040 |
Why?
| Complement C3d | 1 | 2017 | 60 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 385 | 0.040 |
Why?
| Complement C3 | 1 | 2017 | 190 | 0.030 |
Why?
| Myocardial Ischemia | 1 | 2018 | 237 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2019 | 348 | 0.030 |
Why?
| Immunoglobulin M | 1 | 2017 | 254 | 0.030 |
Why?
| Arachidonic Acid | 1 | 2016 | 117 | 0.030 |
Why?
| Immunocompetence | 1 | 2016 | 41 | 0.030 |
Why?
| Oncogene Proteins, Fusion | 1 | 2017 | 178 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 116 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6165 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 146 | 0.030 |
Why?
| Organ Culture Techniques | 2 | 2007 | 143 | 0.030 |
Why?
| Kidney Function Tests | 1 | 2015 | 141 | 0.030 |
Why?
| Homozygote | 1 | 2015 | 186 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 704 | 0.030 |
Why?
| Ventricular Function, Left | 1 | 2018 | 467 | 0.030 |
Why?
| Chemokines | 1 | 2016 | 214 | 0.030 |
Why?
| Caspase 3 | 1 | 2015 | 237 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 317 | 0.030 |
Why?
| Proto-Oncogene Proteins c-sis | 2 | 2005 | 35 | 0.030 |
Why?
| Tetrahydronaphthalenes | 1 | 2014 | 31 | 0.030 |
Why?
| Carcinogenesis | 1 | 2016 | 178 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 445 | 0.030 |
Why?
| Intracellular Space | 1 | 2014 | 68 | 0.030 |
Why?
| Chemokine CCL2 | 1 | 2014 | 105 | 0.030 |
Why?
| Heart | 1 | 2018 | 608 | 0.030 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 18 | 0.030 |
Why?
| Pyridazines | 1 | 2014 | 46 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2014 | 83 | 0.030 |
Why?
| Ventricular Myosins | 1 | 2014 | 33 | 0.030 |
Why?
| Clone Cells | 1 | 2014 | 248 | 0.030 |
Why?
| Superoxides | 1 | 2014 | 215 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 126 | 0.030 |
Why?
| Cardiomegaly | 1 | 2014 | 161 | 0.030 |
Why?
| Hypoglycemic Agents | 2 | 2011 | 1008 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2022 | 1447 | 0.030 |
Why?
| Imidazoles | 1 | 2014 | 217 | 0.030 |
Why?
| Integrases | 1 | 2014 | 117 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2017 | 413 | 0.030 |
Why?
| Calcium-Binding Proteins | 1 | 2014 | 203 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1048 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2016 | 449 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 168 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 639 | 0.030 |
Why?
| Femoral Artery | 1 | 2014 | 167 | 0.030 |
Why?
| Capillary Leak Syndrome | 1 | 2011 | 13 | 0.020 |
Why?
| Chemokine CXCL1 | 1 | 2011 | 66 | 0.020 |
Why?
| Vasoconstriction | 1 | 2012 | 185 | 0.020 |
Why?
| Benzamides | 1 | 2012 | 168 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 1265 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 398 | 0.020 |
Why?
| Cell Lineage | 1 | 2012 | 310 | 0.020 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 181 | 0.020 |
Why?
| Snail Family Transcription Factors | 1 | 2010 | 19 | 0.020 |
Why?
| Regional Blood Flow | 1 | 2012 | 414 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 350 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2010 | 77 | 0.020 |
Why?
| Spleen | 1 | 2011 | 492 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 87 | 0.020 |
Why?
| Interleukin-10 | 1 | 2011 | 299 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2011 | 370 | 0.020 |
Why?
| Pyrimidines | 1 | 2012 | 376 | 0.020 |
Why?
| Metabolomics | 1 | 2013 | 538 | 0.020 |
Why?
| Myocardium | 1 | 2014 | 926 | 0.020 |
Why?
| Intramolecular Oxidoreductases | 1 | 2008 | 56 | 0.020 |
Why?
| Cell Adhesion | 1 | 2010 | 433 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 425 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 108 | 0.020 |
Why?
| Prognosis | 1 | 2016 | 3339 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2008 | 166 | 0.020 |
Why?
| Sulindac | 1 | 2007 | 17 | 0.020 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 49 | 0.020 |
Why?
| Culture Media | 1 | 2007 | 156 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2007 | 271 | 0.020 |
Why?
| Transgenes | 1 | 2007 | 169 | 0.020 |
Why?
| Neoplasms, Experimental | 1 | 2007 | 153 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2008 | 258 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1137 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 3 | 0.020 |
Why?
| Genes, jun | 1 | 2005 | 9 | 0.020 |
Why?
| Blood Pressure | 1 | 2012 | 1537 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 34 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 15 | 0.020 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 14 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 325 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2005 | 340 | 0.010 |
Why?
| Genotype | 1 | 2008 | 1787 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1870 | 0.010 |
Why?
| Heparin Lyase | 1 | 2003 | 4 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 746 | 0.010 |
Why?
| Cattle | 1 | 2004 | 935 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 804 | 0.010 |
Why?
| Binding Sites | 1 | 2003 | 1177 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 2003 | 465 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1999 | 73 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1999 | 298 | 0.010 |
Why?
| Muscle Development | 1 | 1999 | 93 | 0.010 |
Why?
| Tissue Distribution | 1 | 1999 | 324 | 0.010 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1316 | 0.010 |
Why?
| Gestational Age | 1 | 1999 | 758 | 0.010 |
Why?
| Models, Biological | 1 | 2003 | 1646 | 0.010 |
Why?
| DNA | 1 | 1999 | 1356 | 0.010 |
Why?
|
|
Weiser-Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|